IR

IRIX

$0.67510
Listing Nasdaq has marked this issuer deficient against its continued-listing rules. A listing-standards matter, not a Sharia one, and not our assessment — it is the exchange's, from its published symbol directory.
Sharia status
COMPLIANT
Per our secondary compliance provider · assessed 2026-08-25

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
🔴 AVOID
The main driver: lagging the market by 19.7%. Too many signals pointing the wrong way. Wait for the picture to...
44
of 100
Setup confidence — system conviction, not win probabilityD
Why this signal?
Structure1 of 5 timeframes bullish · 87.0% aligned
VWAPPrice below VWAP ($0.69)
VolumeRelative volume 3.5× the 20-day average
Momentum10-day rate of change -3.9%
Overall readAVOID

IRIDEX Corp. (IRIX) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Wall Street consensus
BUY
7 analysts
Price target
$2.75
+307.3% · 1 analysts
Institutional own.
19.5%
of shares
Momentum (10d)
-3.9%
rate of change
SMC grade
D · 44
87.0% aligned
COMPLIANT
Sharia compliance
D · 44
SMC grade — 87.0% timeframe alignment
-3.9%
Rate of change (10d)
BUY
Wall Street consensus (7)
$2.75
Price target (+307.3%) · 1 analysts
19.5%
Institutional ownership

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for IRIX — this runs off the critical path so the page paints first. It will appear here on its own.

1.561.341.120.900.682025-09-112026-03-122026-09-10

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
0.64
S2
0.66
S1
0.67
PIVOT
0.69
R1
0.70
R2
0.72
R3
0.73

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
0.584284 0.875316
±19.94% from 0.7298, made 2026-09-02 · resolves 2026-09-09
STRONG SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 21866 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsSTRONG BUY
4 buy · 1 neutral · 2 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)28.50BUY
Stochastic %K (14)18.18BUY
CCI (20)-97.20NEUTRAL
Williams %R (14)-81.82BUY
MACD (12,26,9)0.00BUY
ROC (10)-4.22SELL
Momentum (10)-0.03SELL
EMA (10)0.71SELL
SMA (10)0.70SELL
EMA (20)0.74SELL
SMA (20)0.75SELL
EMA (30)0.78SELL
SMA (30)0.78SELL
EMA (50)0.85SELL
SMA (50)0.87SELL
EMA (100)0.94SELL
SMA (100)0.98SELL
EMA (200)1.04SELL
SMA (200)1.10SELL

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About IRIDEX Corp.

Healthcare · Medical Devices

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

iridex.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Verdict

🔴 AVOID

The main driver: lagging the market by 19.7%. Too many signals pointing the wrong way. Wait for the picture to improve before committing capital.

Scores: 2 bullish / 3 bearish

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

TimeframeBiasBars
📅 Daily BEARISH 62
⏰ 4H BEARISH 16
🕐 1H BEARISH 67
⏱ 15-Min RANGING 130
⏲ 5-Min BULLISH 234

Momentum & Volume

-0.06
MACD (no fresh cross)

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.